Rapid Enrollment
First global site to enroll three patients in a Phase III colorectal cancer trial, accelerating recruitment and study momentum.
Advancing Oncology Research with Deep Clinical Expertise and Early-Phase Infrastructure
Flourish Research delivers rapid startup and enrollment for oncology clinical trials across the development spectrum, including first-in-human studies and dose escalation trials.
Our wholly-owned oncology sites have experience with solid tumors and hematologic malignancies. We also have recognized expertise in immunotherapy trials, where patient safety and operational precision are critical.
Learn more below or connect with our team to discuss how Flourish can advance your next oncology trial.
Comprehensive Oncology Clinical Trial Expertise
Trial Experience
Flourish teams have experience conducting complex oncology clinical trials across early-phase, Phase III, and basket trial designs.
Our investigators routinely manage complex protocols, including trials for novel immuno-oncology agents requiring specialized safety monitoring. We support studies across the treatment continuum, from frontline oncology trials to pretreated patient populations on later-line treatments.
Indications Expertise
Our oncology sites support research across a broad range of solid tumor and hematologic malignancy studies, including lung, pancreatic, colorectal, breast, prostate, ovarian, melanoma, and multiple myeloma.
Mechanisms of Action Experience
Flourish investigators have experience evaluating a wide range of oncology therapeutics, including cytotoxic, targeted, and immune-based therapies.
Our teams have supported studies involving advanced immunotherapy approaches such as bispecific T-cell engagers, STING agonists, and adoptive cell therapies, with clinical teams experienced in associated safety monitoring.
Rapid Patient Recruitment for Oncology Clinical Trials
Supporting recruitment across both frontline and later-line treatment settings, Flourish Research oncology sites are supported by strong physician relationships and referral networks that enable rapid identification of eligible patients.
Typical recruitment snapshot: 24-hour referral response, three days to patient visit, and treatment within two weeks.
Recent Oncology Successes
Superior Quality
Recognized by the sponsor as a "Protocol Adherence Champion" for maintaining zero protocol deviations throughout the study.
Programmatic Development & Speed
For an NSCLC program, we were the highest-enrolling site worldwide and supported the study from Phase I through Phase III, enabling a seamless transition and helping bring the therapy to market in under two years.
Purpose-Built Infrastructure for Early-Phase Oncology
Flourish oncology capabilities are designed to meet the needs of complex trials while safeguarding patient safety.
ICU-Connected Clinical Research Unit
One of our clinical research units is directly connected to a hospital ICU, enabling immediate escalation of care when required to support patient safety during high-acuity oncology trials.
Key features include:
- Immediate transfer capability for severe immune-related adverse events, such as cytokine release syndrome (CRS)
- Access to mechanical ventilation and vasopressor support
- 10-bed capacity
- Five treatment rooms (accommodating patients and caregivers)
- On-site crash carts and emergency response protocols
- 24-hour physician, nursing, and clinical staff coverage
This infrastructure enables safe execution of:
- First-in-human studies
- Complex dose-escalation designs
- Immunotherapy trials
Quality, Compliance & Regulatory Excellence
Oncology trials require strict compliance standards. Our sites maintain:
- GCP-trained oncology research staff
- Robust quality assurance processes
- Audit-ready documentation practices
- Experienced oncology principal investigators
We prioritize data integrity, patient safety, and sponsor transparency throughout the study lifecycle.
Leaders in Oncology Trial Delivery
David Berz MD, MPH, PhD
Principal Investigator, Founder of Valkyrie Clinical Trials
Olachi Opara NP
Study Nurse
Partner With Flourish Research for Your Next Oncology Trial
Whether you are launching an early-phase oncology study or expanding a late-phase program, Flourish Research provides the operational strength, patient access, and therapeutic expertise to support your clinical development goals. Contact our team today to discuss your upcoming oncology protocol.
Flourish Research News
Stay current with the latest clinical trial news and learn how Flourish Research is supporting the advancement of life-changing therapeutics.